397 related articles for article (PubMed ID: 27909742)
1. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
Said MM; Bosland MC
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
[TBL] [Abstract][Full Text] [Related]
2. The phytotherapeutic agent, eviprostat, suppresses stromal proliferation and inflammation even after establishment of nonbacterial prostatitis in the rat prostate.
Shibuya S; Xia Z; Sugimoto M; Ueda N; Haba R; Kakehi Y
Urology; 2014 Mar; 83(3):528-34. PubMed ID: 24581515
[TBL] [Abstract][Full Text] [Related]
3. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate.
Oka M; Ueda M; Oyama T; Kyotani J; Tanaka M
Prostate; 2009 Sep; 69(13):1404-10. PubMed ID: 19489033
[TBL] [Abstract][Full Text] [Related]
4. Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules.
Maeba S; Ichiyama T; Ueno Y; Makata H; Matsubara T; Furukawa S
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):670-4. PubMed ID: 15984600
[TBL] [Abstract][Full Text] [Related]
5. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
Al-Amran FG; Hadi NR; Hashim AM
Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
[TBL] [Abstract][Full Text] [Related]
6. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
7. Montelukast rescues primary neurons against Aβ1-42-induced toxicity through inhibiting CysLT1R-mediated NF-κB signaling.
Lai J; Mei ZL; Wang H; Hu M; Long Y; Miao MX; Li N; Hong H
Neurochem Int; 2014 Sep; 75():26-31. PubMed ID: 24879954
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat.
Wilson MJ; Woodson M; Wiehr C; Reddy A; Sinha AA
Exp Mol Pathol; 2004 Aug; 77(1):7-17. PubMed ID: 15215045
[TBL] [Abstract][Full Text] [Related]
9. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Shimbori C; Shiota N; Okunishi H
Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
[TBL] [Abstract][Full Text] [Related]
10. Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate.
Harris MT; Feldberg RS; Lau KM; Lazarus NH; Cochrane DE
Prostate; 2000 Jun; 44(1):19-25. PubMed ID: 10861753
[TBL] [Abstract][Full Text] [Related]
11. Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells.
Kuo CH; Yang SN; Kuo HF; Lee MS; Huang MY; Huang SK; Lin YC; Hsieh CC; Hung CH
Pulm Pharmacol Ther; 2016 Aug; 39():28-37. PubMed ID: 27312202
[TBL] [Abstract][Full Text] [Related]
12. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
[TBL] [Abstract][Full Text] [Related]
13. Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats.
Saad MA; Abdelsalam RM; Kenawy SA; Attia AS
Neurochem Res; 2015 Jan; 40(1):139-50. PubMed ID: 25403620
[TBL] [Abstract][Full Text] [Related]
14. A leukotriene receptor antagonist modulates iNOS in the lung and in a leukotriene-free cell model.
Offer S; Shoseyov D; Bibi H; Eliraz A; Madar Z
Nitric Oxide; 2003 Aug; 9(1):10-7. PubMed ID: 14559427
[TBL] [Abstract][Full Text] [Related]
15. Montelukast protects against renal ischemia/reperfusion injury in rats.
Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC
Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of the cys-leukotriene-1 receptor antagonist, montelukast, on experimental colitis in rats.
Holma R; Salmenperä P; Riutta A; Virtanen I; Korpela R; Vapaatalo H
Eur J Pharmacol; 2001 Oct; 429(1-3):309-18. PubMed ID: 11698051
[TBL] [Abstract][Full Text] [Related]
17. Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Aβ1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice.
Lai J; Hu M; Wang H; Hu M; Long Y; Miao MX; Li JC; Wang XB; Kong LY; Hong H
Neuropharmacology; 2014 Apr; 79():707-14. PubMed ID: 24456746
[TBL] [Abstract][Full Text] [Related]
18. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic potential of montelukast against mild colitis induced by dextran sulphate sodium in rats.
Holma R; Salmenperä P; Virtanen I; Vapaatalo H; Korpela R
J Physiol Pharmacol; 2007 Sep; 58(3):455-67. PubMed ID: 17928642
[TBL] [Abstract][Full Text] [Related]
20. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.
Zhou C; Shi X; Huang H; Zhu Y; Wu Y
Anesth Analg; 2014 May; 118(5):1090-6. PubMed ID: 24686047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]